Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DATE-AGING
NCT07294209Phase 4Completed
- Sponsor
- Southwest Health System
- Start
- Dec 2025
- Primary completion
- Nov 2026
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of tenecteplase in ischemic stroke, sponsored by Southwest Health System. Started Dec 2025; status: completed.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07294209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07294209.